Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy

Journal of the Peripheral Nervous System

Volumn 9, Issue 3, 2004, Pages 183-189

  Windebank, Anthony J ^a,c   Sorenson, Eric J ^a   Civil, Richard ^b   O'Brien, Peter C ^a  

^a Mayo Clinic   (United States)

^b CEPHALON INC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Axonal growth; Insulin like growth factor I; Nerve growth factor; Painful neuropathy; Peripheral neuropathy

Indexed keywords

PLACEBO; RECOMBINANT SOMATOMEDIN C;

ADULT; APOPTOSIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INJECTION PAIN; MALE; MYELINATION; NERVE CELL; NERVE CONDUCTION; NERVE FIBER; NERVE FIBER REGENERATION; PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY EVALUATION; VISUAL ANALOG SCALE;

ADULT; AGED; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 4944263592     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2004.09311.x     Document Type: Article

References (34)

1. Ahlskog JE, Aksamit AJ, Aronson AE, Auger RG, Bartleson JD, Campbell JK, Cascino TL, Cross SA, Dale AJD, Daube JR, Dinapoli RP, Duffy JR, Dyck PJ, Engel AG, Espinosa RE, Evans BA, Fealey RD, Folger WN, Gomez MR, Grabow JD, Groover RV, Harper CMJ, Hermann RCJ, Karnes WE, Kimmel DW, Klass DW, Kokmen E, Krueger BR, Lagerlund TD, Layton DDJ, Litchy WJ, Low PA, McManis PG, Mokri B, O'Neill BP, Petersen RC, Rodriguez M, Sandok BA, Sharbrough FW, Siekert RG, Stevens JC, Swanson JW, Thomas JE, Westmoreland BF, Whisnant JP, Wiebers DO, Windebank AJ, Yanagihara T (1991). Clinical Examinations in Neurology. 6th edn. Mosby Year Book, St. Louis.
2. Apfel SC (1996). Neurotrophic factors in the treatment of neurotoxicity: an overview. Neurotoxicology 17:839-844.
3. Apfel SC (1999). Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol 9:393-413.
4. Apfel SC, Arezzo JC, Lewis ME, Kessler JA (1993). The use of insulin-like growth factor I in the prevention of vincristine neuropathy in mice. Ann N Y Acad Sci 692:243-245.
5. Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, Silani V, Vos PE, Wokke JHJ, Dobbins T, Group EAI-IS (1998). A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Neurology 51:583-586.
6. Contreras PC, Vaught JL, Gruner JA, Brosnan C, Steffler C, Arezzo JC, Lewis ME, Kessler JA, Apfel SC (1997). Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice. Brain Res 774:20-26.
7. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJI, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR (1991). The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807.
8. Dyck PJ, Lambert EH, O'Brien PC (1976). Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 26:466-471.
9. Dyck PJ, Zimmerman I, Gillen DA, Johnson D, Karnes JL, O'Brien PC (1993). Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors. Neurology 43:1500-1508.
10. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O'Brien PC (1996). A standard test of heat-pain responses using CASE IV. J Neurol Sci 136:54-63.
11. Feldman EL, Windebank AJ (1999). Growth factors and peripheral neuropathy. In: Diabetic Neuropathy, 2nd edn. Dyck PJ, Thomas PK (Eds). W.B. Saunders Company, Philadelphia, pp 377-386.
12. Gao WQ, Shinsky N, Ingle G, Beck K, Elias KA, Powell-Braxton L (1999). IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J Neurobiol 39:142-152.
13. Glazner GW, Lupien S, Miller JA, Ishii DN (1993). Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats. Neuroscience 54:791-797.
14. Hansson H-A, Nilsson A, Isgaard J, Billig H, Isaksson O, Skottner A, Andersson IK, Rozell B (1988). Immunohistochemical localization of insulin-like growth factor I in the adult rat. Histochemistry 89:403-410.
15. Ishii DN (1989). Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis. Proc Natl Acad Sci USA 86:2898-2902.
16. Ishii DN (1993). Neurobiology of insulin and insulin-like growth factors. In: Neurotrophic Factors. Loughlin SE, Fallon JH (Eds). Academic Press, New York, pp 415-442.
17. Ishii DN, Glazner GW, Pu S-F (1994). Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther 62:125-144.
18. Ishii DN, Lupien SB (1995). Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 40:138-144.
19. Kanje M, Skottner A, Sjöberg J, Lundborg G (1989). Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res 486:396-398.
20. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA, The North America ALS/IGF-I Study Group (1997). Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. Neurology 49:1621-1630.
21. Lewis ME, Vaught JL, Neff NT, Grebow PE, Callison KV, Yu E, Contreras PC, Baldino FJ (1993). The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders. Ann N Y Acad Sci 692:201-208.
22. Low PA, Fealey RD (1987). Sudomotor neuropathy. In: Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte DJ (Eds). W.B. Saunders Company, Philadelphia, pp 140-145.
23. MacPherson RD (2000). The pharmacological basis of contemporary pain management. Pharmacol Ther 88:163-185.
24. Novak V, Freimer ML, Kissel JT, Sahenk Z, Periquet IM, Nash SM, Collins MP, Mendell JR (2001). Autonomic impairment in painful neuropathy. Neurology 56:861-868.
25. Ocrant I (1993). Insulin-like growth factor binding proteins in nervous-tissue-derived cells. Ann N Y Acad Sci 692:44-50.
26. Pfeiffer MA, Peterson H (1987). Cardiovascular autonomic neuropathy. In: Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte DJ (Eds). W.B. Saunders Company, Philadelphia, pp 122-133.
27. Reading AE (1984). Testing pain mechanisms in persons in pain. In: Textbook of Pain. Wall PD, Melzack R (Eds). Churchill Livingstone, Edinburgh, pp 195-204.
28. Revill SI, Robinson JO, Rosen M, Hogg MI (1976). The reliability of a linear analogue for evaluating pain. Anaesthesia 31:1191-1198.
29. Russell JW, Windebank AJ, Schenone A, Feldman EL (1998). Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 36:455-467.
30. Sjöberg J, Kanje M (1989). Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res 485:102-108.
31. Turner J, Deyo RA, Loesser J, Von Korff M, Fordyce WE (1994). The importance of placebo effects in pain treatment and research. JAMA 271:1609-1614.
32. Windebank AJ (1987). Clinical evaluation of motor function. In: Diabetic Neuropathy, 1st Edn. Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte DJ (Eds). W.B. Saunders Company, Philadelphia, pp 100-106.
33. Zackenfels K, Rohrer H (1993). IGF-I stimulates chick sympathetic neuron proliferation in vitro and in vivo. Ann N Y Acad Sci 692:302-304.
34. Zochodne DW, Cheng C (2000). Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips. J Anat 196:279-283.